INTRODUCTION
The clinical expression of SC disease is moderately severe. It cannot be predicted from the in vitro interactions of HbS and C. The minimum gelling concentration of 50-50 mixtures of HbS and HbC is only 2 g per 100 dl lower than equivalent mixtures between HbA and HbS (1) . On the other hand, the sickling rates of SC cells are similar to SS cells and not AS cells, (2) (even when compared with a theoretical AS cell with 50% S) and follow closely the differences in clinical severity.
The work presented here resolves this paradox and illustrates that cellular factors, as well as the solution behavior, have to be considered in order to understand the sickling process. This work was presented at the 95th Annual Meeting of the Association of American Physicians, Washington, DC, 7-11 May 1982. Received for publication 30 June 1982 and in revised form 7 September 1982.
J. Clin. Invest. The American Society for Clinical Investi from donors characterized as SC at our Heredity Unit and used within 24 h for all studies.
Density gradients. Percoll (collodial silica coated with polyvinylpyrrolidone; Pharmacia, Inc., Piscataway, NJ)-Stractan (arabino-galactan polysaccharide; St. Regis Paper Co., West Nyack, NY) gradients were formed as previously described (3) . The hematocrit of each blood sample was adjusted to 40 and 0.1 ml was added to 5.9 ml of the gradient mixture and mixed by inversion. Samples were centrifuged in a Sorvall SS-34 rotor at 17,000 rpm for 45 min at 38°C (Sorvall Instrument Co., Newtown, CN).
Percoll-Stractan gradients can also be used to determine the osmolarity at which the density ( (4) . Samples taken before and after viscometric measurements showed <5% change in oxygen saturation. Osmolarity of the supernatant was checked both before and after viscosity measurements.
Sickling rates. The rate of sickling was measured by a syringe technique as previously described (2) with the exception that the 0.1 ml whole blood in 5 ml of pH 7.4 sodium phosphate-buffered saline adjusted to either 235 or 295 mosM was added to 5 ml of the same buffer containing 1 mg/ml of sodium dithionite.
Potassium efflux. Oxygen equilibria. The Imai cell technique was used, as previously described (6) .
RESULTS
Density distribution in SC erythrocytes. We have examined the blood of 20 SC patients using PercollStractan continuous density gradients and find that their cells are much more dense than AA cells ( Fig.  1 ) with an average MCHC of 36.4±0.76 g/dl (mean and standard deviation) determined from the depth on the gradient, a procedure described in detail in ref. 7 . The cells are symmetrically distributed around the average density. In somewhat less than half of the cases, a small number of very dense cells are found, some of which are similar to irreversibly sickled cells (ISC). They usually represent <5% of the total number of cells and are slightly more dense than the ISC found in SS patients. The reticulocytes of SC patients are more dense than those found in AA individuals (Fig.  1) . AC cells were also found to be more dense than AA cells (Fig. 1) Potassium efflux in SC cells and the effect of MCHC correction. The deoxygenation-dependent potassium Time (minutes) FIGURE 6 Effect of osmolarity on (Fig. 7) .
DISCUSSION
The data presented here demonstrate that cells containing both HbS and HbC have an elevated MCHC of -37 g/dl, higher than both normal cells (MCHC = 33 g/dl) and the reversibly sickled cell fraction of SS cells (average MCHC 33-34 g/dl) (3). The increase in density is an early development in the life of the cell, since SC reticulocytes are more dense than either normal or SS reticulocytes. Elevated MCHC can be attributed to the presence of HbC since the MCHC of cells from homozygotes for HbC of both reticulocytes and mature erythrocytes is even higher (MCHC = 38 g/dl) as demonstrated by Fabry et al. (8) . Because SC cells maintain discoid morphology even after their MCHC is lowered to 33 g/dl, we propose that their elevated MCHC is the result of water loss and not primarily due to an abnormal ratio of membrane area to hemoglobin or loss of membrane.
Because of the presence of HbS, these cells also have properties that result from the intracellular polymerization of HbS (a) they sickle on deoxygenation with a rate similar to SS cells (2), (b) there is a dramatic deoxygenation-linked increase in the efflux of K+ (reported here for the first time), that is even higher than the well known effect found in SS cells (9) (Fig. 7) , (c) cell viscosity increases after deoxygenation, and (d) oxygen affinity is decreased.
As stated earlier, the magnitude of these abnormalities is surprising when the modest differences in minimum gelling concentration for HBS and HbC solutions are compared with solutions containing HbS and HbA (1). Moreover, Bunn et al. (10) using an equilibrium method for the study of polymerization, find even less difference between SC and AS hemoglobin mixtures.
The results presented here resolve one aspect of this paradox: the abnormalities that result from the presence of HbS are magnified by the significant increase of the MCHC found in these cells. This is the consequence of the exquisite dependency of HbS polymerization on initial concentration for both the extent and kinetics of the phase change as demonstrated by the pioneer work of Hofrichter and Eaton (11) .
This hypothesis is confirmed here by the correction of four of the HbS-dependent abnormal properties when the elevated MCHC of SC cells is normalized. The right shift of the oxygen equilibrium is almost entirely abolished, the deoxygenation-dependent increase in viscosity is drastically reduced (Fig. 5) , and the sickling rates are reduced to values near to those of AS cells (Fig. 6 ). In addition, the deoxygenationdependent K' efflux is reduced but not abolished (Fig.  7 ). An understanding of why the K+ efflux is not abolished will have to await the elucidation of the mechanism of potassium loss as well as an explanation for the enhanced rate of loss in SC cells, beyond that observed for SS cells, under isotonic conditions. Two factors that also contribute to enhanced sickling of SC cells, are the higher proportion of HbS (50 vs. 40%) compared with AS cells and the lower minimum gelling concentration of 50% mixtures of HbS and C when compared with 50% mixtures of HbS and A. However, the efficacy of normalizing the MCHC in correcting the four abnormal properties described above indicates the dominant role played by MCHC in the SC cell. These observations have practical implications. Interest has been generated recently in treatment of sickle disease by decreasing intracellular HbS concentration. Our in vitro results with SC cells demonstrate the potential usefulness of such an approach since four physiologically important properties (oxygen affinity, deoxy viscosity, sickling rates and deoxy-induced K+ efflux) have been restored to more normal values by reducing the MCHC (12) . Furthermore, discocyte morphology, which is crucial for successful transit of the microcirculation in vivo, was maintained. This approach appears promising because of two factors: (a) the change in MCHC needed to correct the abnormalities is small (only 37 to 33 g/dl) and (b) the elevated MCHC was due to dehydration, which means that the cell volume could be increased with retention of normal morphology.
This approach is less likely to be successful for sickle cells because (a) the change in MCHC needed to significantly delay polymerization in homozygous cells is large (reduction to 25 g/dl), and (b) because the reversibly sickled cells have an average MCHC to 33-34 g/dl (ref. 3 and Fig. 1 ), large volume increases will convert these discocytes into near spherocytes, which are much less deformable. This could turn a good approach into an exchange of equally unwelcome properties.
We can conclude that the modification of intracellular hemoglobin concentration is an attractive avenue of approach, when considering therapeutic modalities intended for SC disease.
